We are live on
!
Find out more
BAMCO Inc Portfolio holdings
AUM
$33.1B
1-Year Est. Return
11.16%
This Fund
S&P 500
This Quarter
Est. Return
-9.26%
1 Year Est. Return
+11.16%
3 Year Est. Return
+63.39%
5 Year Est. Return
+85.45%
10 Year Est. Return
+744.36%
AUM
$33.1B
AUM Growth
-$3.78B
(-10%)
Cap. Flow
+$637M
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
41.49%
Holding
362
New
35
Increased
114
Reduced
147
Closed
36
Top Buys
| 1 |
Shopify
SHOP
|
+$319M |
| 2 |
Gartner
IT
|
+$314M |
| 3 |
Verisk Analytics
VRSK
|
+$245M |
| 4 |
Guidewire Software
GWRE
|
+$221M |
| 5 |
Factset
FDS
|
+$203M |
Top Sells
| 1 |
CWAN
Clearwater Analytics
CWAN
|
+$181M |
| 2 |
CoStar Group
CSGP
|
+$166M |
| 3 |
Arch Capital
ACGL
|
+$122M |
| 4 |
Microsoft
MSFT
|
+$112M |
| 5 |
Idexx Laboratories
IDXX
|
+$106M |
Sector Composition
| 1 | Consumer Discretionary | 33.6% |
| 2 | Financials | 21.27% |
| 3 | Technology | 17.34% |
| 4 | Industrials | 8.63% |
| 5 | Healthcare | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEI
276
Solaris Energy Infrastructure
SEI
$4.26B
| $2.2M | 0.01% |
+38,970
| New | +$2.11M |
|
277
Palantir
PLTR
$321B
| $1.9M | 0.01% |
+13,005
| New | +$1.99M |
|
|
TERN
278
DELISTED
Terns Pharmaceuticals
TERN
| $1.85M | 0.01% |
+35,000
| New | +$1.44M |
|
279
Stryker
SYK
$119B
| $1.81M | 0.01% |
5,500
-2,500
| -31% | -$898K |
|
280
Synopsys
SNPS
$81.6B
| $1.77M | 0.01% |
4,473
-18,782
| -81% | -$8.49M |
|
281
AbbVie
ABBV
$432B
| $1.74M | 0.01% |
8,000
-16,800
| -68% | -$3.73M |
|
282
Kymera Therapeutics
KYMR
$9.22B
| $1.67M | 0.01% |
20,000
| – | – |
|
283
Protagonist Therapeutics
PTGX
$8.44B
| $1.58M | ﹤0.01% |
15,000
+6,700
| +81% | +$593K |
|
284
HDFC Bank
HDB
$133B
| $1.57M | ﹤0.01% |
63,292
-48,579
| -43% | -$1.51M |
|
285
Cytokinetics
CYTK
$11.1B
| $1.52M | ﹤0.01% |
+23,000
| New | +$1.46M |
|
286
Morgan Stanley
MS
$359B
| $1.5M | ﹤0.01% |
9,100
+2,500
| +38% | +$433K |
|
287
Xenon Pharmaceuticals
XENE
$6.51B
| $1.45M | ﹤0.01% |
25,000
-5,000
| -17% | -$230K |
|
288
Bank of America
BAC
$430B
| $1.37M | ﹤0.01% |
+28,200
| New | +$1.46M |
|
289
Ascendis Pharma A/S
ASND
$17.4B
| $1.28M | ﹤0.01% |
5,600
| – | – |
|
290
Apogee Therapeutics
APGE
$10.1B
| $1.26M | ﹤0.01% |
+15,000
| New | +$1.09M |
|
291
Douglas Emmett
DEI
$2.09B
| $1.17M | ﹤0.01% |
124,363
| – | – |
|
292
Micron Technology
MU
$1.11T
| $1.13M | ﹤0.01% |
3,347
-3,004
| -47% | -$1.18M |
|
293
Capital One
COF
$126B
| $1.09M | ﹤0.01% |
6,000
-135
| -2% | -$28.2K |
|
294
Blackrock
BLK
$159B
| $1.07M | ﹤0.01% |
1,110
+58
| +6% | +$61K |
|
295
ODDITY Tech
ODD
$754M
| $838K | ﹤0.01% |
62,630
-1,291,085
| -95% | -$32.4M |
|
296
Jack Henry & Associates
JKHY
$10.3B
| $793K | ﹤0.01% |
5,016
-94
| -2% | -$16.1K |
|
297
Berkshire Hathaway Class A
BRK.A
$1.06T
| $718K | ﹤0.01% |
1
| – | – |
|
298
Progressive
PGR
$132B
| $684K | ﹤0.01% |
3,452
-128
| -4% | -$26.4K |
|
299
Goldman Sachs
GS
$336B
| $677K | ﹤0.01% |
800
| – | – |
|
300
Lattice Semiconductor
LSCC
$18.3B
| $676K | ﹤0.01% |
7,292
+3,465
| +91% | +$311K |
|
Similar funds
PPF
GAM
TWC
